Provided by Tiger Trade Technology Pte. Ltd.

CSL Ltd.

61.42
+1.372.28%
Post-market: 59.20-2.2200-3.61%16:03 EST
Volume:129.23K
Turnover:7.91M
Market Cap:59.30B
PE:27.95
High:62.19
Open:62.19
Low:60.67
Close:60.05
52wk High:90.40
52wk Low:54.10
Shares:965.53M
Float Shares:962.56M
Volume Ratio:0.81
T/O Rate:0.01%
Dividend:1.41
Dividend Rate:2.30%
EPS(TTM):2.20
EPS(LYR):2.40
ROE:15.37%
ROA:6.63%
PB:3.07
PE(LYR):25.54

Loading ...

Company Profile

Company Name:
CSL Ltd.
Exchange:
OTCQX
Establishment Date:
1916
Employees:
29904
Office Location:
655 Elizabeth Street,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9389 1434
Introduction:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.